Sun Pharmaceutical Industries and Moebius Medical said that the United States Food and Drug Administration (USFDA) has granted Fast Track Designation (FTD) to its MM-II (large Liposomes of DPPC and DMPC) for treatment of osteoarthritis knee pain.
| Subscribe To Our Free Newsletter |
